CONMED Corporation

Informe acción NYSE:CNMD

Capitalización de mercado: US$2.2b

CONMED Dirección

Dirección controles de criterios 3/4

El CEO de CONMED's es Curt Hartman , nombrado en Jul 2014, tiene una permanencia de 9.75 años. compensación anual total es $7.76M, compuesta por 12.2% salario y 87.8% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.29% de las acciones de la empresa, por valor de $6.26M. La antigüedad media del equipo directivo y de la junta directiva es de 9 años y 8.8 años, respectivamente.

Información clave

Curt Hartman

Chief Executive Officer (CEO)

US$7.8m

Compensación total

Porcentaje del salario del CEO12.2%
Permanencia del CEO9.8yrs
Participación del CEO0.3%
Permanencia media de la dirección9yrs
Promedio de permanencia en la Junta Directiva8.8yrs

Actualizaciones recientes de la dirección

Recent updates

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Apr 18
Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Is CONMED (NYSE:CNMD) Using Too Much Debt?

Mar 28
Is CONMED (NYSE:CNMD) Using Too Much Debt?

CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%

Feb 15
CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%

US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results

Feb 03
US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results

Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?

Jan 08
Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?

Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects

Dec 18
Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects

CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt

Nov 30
CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt

Conmed: Sector Derating And A New Competitive Threat Shouldn't Overshadow A Solid Core Business

Oct 28

Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?

Sep 22
Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?

Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?

Aug 24
Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?

Conmed: Reiterate Buy Rating As Earnings Are Expected To Grow Strongly

Jul 28

Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?

Jun 08
Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?

These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively

May 17
These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively

Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Apr 28
Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Mar 10
Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden

Feb 14
Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden

CONMED Non-GAAP EPS of $0.42 misses by $0.48, revenue of $250.9M misses by $51.58M

Feb 02

Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Jan 24
Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

ConMed: Still Fairly Priced, Turning More Constructive

Dec 09

At US$83.60, Is CONMED Corporation (NYSE:CNMD) Worth Looking At Closely?

Nov 18
At US$83.60, Is CONMED Corporation (NYSE:CNMD) Worth Looking At Closely?

Conmed withdraws FY22 guidance on software implementation-related disruption

Nov 15

CONMED (NYSE:CNMD) Has A Pretty Healthy Balance Sheet

Oct 11
CONMED (NYSE:CNMD) Has A Pretty Healthy Balance Sheet

ConMed: Fairly Priced At Pre-Pandemic Market Cap

Sep 21

CONMED (NYSE:CNMD) Has Announced A Dividend Of $0.20

Sep 03
CONMED (NYSE:CNMD) Has Announced A Dividend Of $0.20

CONMED (NYSE:CNMD) Has Affirmed Its Dividend Of $0.20

Aug 18
CONMED (NYSE:CNMD) Has Affirmed Its Dividend Of $0.20

CONMED declares $0.20 dividend

Aug 11

Should You Investigate CONMED Corporation (NYSE:CNMD) At US$98.47?

Jul 20
Should You Investigate CONMED Corporation (NYSE:CNMD) At US$98.47?

We Think CONMED (NYSE:CNMD) Can Stay On Top Of Its Debt

Jun 23
We Think CONMED (NYSE:CNMD) Can Stay On Top Of Its Debt

Here's Why I Think CONMED (NYSE:CNMD) Might Deserve Your Attention Today

Jun 10
Here's Why I Think CONMED (NYSE:CNMD) Might Deserve Your Attention Today

Estimating The Fair Value Of CONMED Corporation (NYSE:CNMD)

May 25
Estimating The Fair Value Of CONMED Corporation (NYSE:CNMD)

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Curt Hartman en comparación con los beneficios de CONMED?
FechaCompensación totalSalarioIngresos de la empresa
Mar 31 2024n/an/a

US$82m

Dec 31 2023US$8mUS$950k

US$64m

Sep 30 2023n/an/a

US$58m

Jun 30 2023n/an/a

US$88m

Mar 31 2023n/an/a

-US$94m

Dec 31 2022US$8mUS$946k

-US$81m

Sep 30 2022n/an/a

-US$83m

Jun 30 2022n/an/a

-US$114m

Mar 31 2022n/an/a

US$68m

Dec 31 2021US$9mUS$918k

US$63m

Sep 30 2021n/an/a

US$62m

Jun 30 2021n/an/a

US$54m

Mar 31 2021n/an/a

US$13m

Dec 31 2020US$6mUS$888k

US$10m

Sep 30 2020n/an/a

US$311k

Jun 30 2020n/an/a

US$431k

Mar 31 2020n/an/a

US$34m

Dec 31 2019US$6mUS$842k

US$29m

Sep 30 2019n/an/a

US$29m

Jun 30 2019n/an/a

US$28m

Mar 31 2019n/an/a

US$31m

Dec 31 2018US$5mUS$791k

US$41m

Sep 30 2018n/an/a

US$72m

Jun 30 2018n/an/a

US$73m

Mar 31 2018n/an/a

US$71m

Dec 31 2017US$3mUS$753k

US$55m

Compensación vs. Mercado: La compensación total de Curt($USD7.76M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD5.55M).

Compensación vs. Ingresos: La compensación de Curt ha sido consistente con los resultados de la empresa en el último año.


CEO

Curt Hartman (59 yo)

9.8yrs

Permanencia

US$7,764,615

Compensación

Mr. Curt R. Hartman has been Chairman of the Board at CONMED Corporation since May 21, 2020. Mr. Hartman has been the Chief Executive Officer and President of CONMED Corporation since November 09, 2014. Mr...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Curt Hartman
Chairman of the Board9.8yrsUS$7.76m0.29%
$ 6.2m
Todd Garner
Executive VP of Finance & CFO6.3yrsUS$2.87m0.00074%
$ 16.0k
Patrick Beyer
Chief Operating Officerless than a yearUS$3.30m0.025%
$ 547.5k
Heather Cohen
Executive VP11.2yrsUS$1.83m0.14%
$ 3.0m
Stanley Peters
President of Advanced Surgical & Advanced Endoscopic Technologies9.3yrsUS$2.00m0.0048%
$ 104.3k
Peter Shagory
Executive Vice President of Strategy & Corporate Development9yrssin datos0.012%
$ 260.2k
Shanna Cotti-Osmanski
Executive VP of Information Technology & CIO4.2yrssin datossin datos
John Ferrell
Executive Vice President of Human Resources1.4yrssin datos0.0023%
$ 49.2k
Daniel Jonas
Special Counsel & Corporate Secretary6yrsUS$1.55m0.044%
$ 944.0k
David Murray
President of ConMed Electrosurgery19.8yrsUS$572.33ksin datos
Terence Berge
VP & Corporate Controller9.1yrssin datos0.0033%
$ 70.4k
Johonna Pelletier
VP of Tax & Treasurer9.1yrssin datos0.0043%
$ 92.4k

9.0yrs

Permanencia media

54yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de CNMD es experimentado (9 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Curt Hartman
Chairman of the Board10.2yrsUS$7.76m0.29%
$ 6.2m
John Workman
Independent Director8.8yrsUS$257.37k0.065%
$ 1.4m
David Bronson
Independent Director8.8yrsUS$264.87k0.049%
$ 1.1m
Brian Concannon
Independent Director10.8yrsUS$257.37k0.030%
$ 654.6k
LaVerne Council
Independent Director4.4yrsUS$257.37k0.011%
$ 229.1k
Martha Aronson
Lead Independent Director8.3yrsUS$292.37k0.038%
$ 814.0k
Jerome Lande
Independent Director10.2yrsUS$257.37k0.012%
$ 249.2k
Charles Farkas
Independent Director9.8yrsUS$249.87k0.064%
$ 1.4m
Barbara Schwarzentraub
Independent Director4.7yrsUS$264.87k0.012%
$ 249.9k

8.8yrs

Permanencia media

61yo

Promedio de edad

Junta con experiencia: La junta directiva de CNMD se considera experimentada (8.8 años de antigüedad promedio).